Global Companion Diagnostics market | Inkwood Research - PowerPoint PPT Presentation

About This Presentation
Title:

Global Companion Diagnostics market | Inkwood Research

Description:

The global companion diagnostics market was valued at $2608 million in 2017 & is estimated to generate net revenue of approximately $11980 million by 2026, growing at a CAGR of 18.45%. – PowerPoint PPT presentation

Number of Views:51

less

Transcript and Presenter's Notes

Title: Global Companion Diagnostics market | Inkwood Research


1
GLOBAL COMPANION DIAGNOSTICS MARKET
  • FORECAST 2018-2026

1
2
MARKET OVERVIEW
GLOBAL COMPANION DIAGNOSTICS MARKET FORECAST
2018-2026
  • The global companion diagnostics market is
    segmented on the basis of technology, products
    and services, indications and end-users.
  • The technology segment includes polymerase chain
    reaction, in situ hybridization,
    immunohistochemistry, next-generation sequencing
    and other technologies.
  • The product and service segment includes assay
    kits and reagents and software and service.
  • The indication segment is further classified into
    oncology, neurology, infectious diseases and
    other indications.
  • The market caters to end-users like
    pharmaceutical and biopharmaceutical companies,
    reference laboratories and other end users.

3
INTRODUCTION
KEY FINDINGS
  • The global companion diagnostics market is driven
    by factors such as the widespread of cancer
    disease across the globe, high demand for target
    therapies and strategic initiatives for companion
    diagnostics test development.
  • By the end of the forecast period of 2018-2026,
    the market is expected to rise with a 18.45 CAGR.
  • Global Companion Diagnostics market by Products
    and Services, by Indication, by End user, by
    Technology by geography.

4
Infographic
5
REQUEST FREE SAMPLE
To know more about the latest trends and
innovation in the Global Companion Diagnostics
market
Request free sample
5
6
NORTH AMERICA COMPANION DIAGNOSTICS MARKET
  • The North America companion diagnostics market is
    projected to rise with a CAGR of 18.62 over the
    forecast period of 2018-2026.
  • Initiatives to promote precision medicine
    research along with the strategic alliances
    between key market players for companion
    diagnostics test development are factors that are
    responsible for propelling the market growth.

Request free sample
6
7
EUROPE COMPANION DIAGNOSTICS MARKET
  • High demand for target therapy and growing
    efforts to develop advanced companion diagnostics
    tests are factors that are driving growth in the
    Europe companion diagnostics market.
  • Over the forecast period of 2018-2026, the Europe
    companion diagnostic market is expected to
    register a CAGR of 18.17.

Request free sample
7
8
ASIA PACIFIC COMPANION DIAGNOSTICS MARKET
  • The Asia-Pacific companion diagnostics market is
    predicted to show the highest CAGR of 18.79 over
    the forecast period of 2018-2026.
  • China, India and Japan are the major contributors
    to this market.

Request free sample
8
9
COMPETITIVE INSIGHTS
  • Leading players in the global companion
    diagnostics market are Abbott Laboratories, Almac
    Group, Arup Laboratories, Biocartis, Biomerieux
    S.A, Danaher Corporation, Ge Healthcare, Genomic
    Health, Illumina Inc, Myriad Genetics Inc, Qiagen
    N.V, Roche Diagnostics (A Hoffmann-La Roche Ag
    Divison), Sysmex Corporation, and Thermo Fisher
    Scientific Inc.

9
10
(No Transcript)
11
CONTACT US
  • 1 857-302-4704
  • sales_at_inkwoodresearch.com
  • https//www.inkwoodresearch.com/

10
12
  • THANK YOU

Follow us on
12
Write a Comment
User Comments (0)
About PowerShow.com